Unknown PHASE1 INTERVENTIONAL 1-arm NCT02394613

A Phase I Clinical Trial of DARC

A Phase I, Storer Design, Open-label, Cross-sectional, Single Site Trial of ANX776 in Healthy Volunteers, Progressive Glaucoma/Glaucoma-suspect/Ocular Hypertensive Subjects and Non-arteritic Anterior Ischaemic Optic Neuropathy Subjects

Sponsor: University College, London

Conditions Glaucoma Glaucoma, Suspect Ocular Hypertension

Interventions ANX776

Updated 6 times since 2017 Last updated: May 25, 2016 Started: May 31, 2015 Primary completion: Nov 30, 2015 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Glaucoma and Glaucoma, Suspect, this trial is ongoing. The trial is conducted by University College, London and has accumulated 6 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Sep 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

Status: Active Not Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Sep 2017 [monthly]

Active Not Recruiting PHASE1

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University College, London
Wellcome Trust

Data source: University College, London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom